Your browser doesn't support javascript.
loading
Topology-Matching Design of an Influenza-Neutralizing Spiky Nanoparticle-Based Inhibitor with a Dual Mode of Action.
Nie, Chuanxiong; Parshad, Badri; Bhatia, Sumati; Cheng, Chong; Stadtmüller, Marlena; Oehrl, Alexander; Kerkhoff, Yannic; Wolff, Thorsten; Haag, Rainer.
Afiliação
  • Nie C; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustr. 3, 14195, Berlin, Germany.
  • Parshad B; Unit 17, Robert Koch Institut, Seestr. 10, 13353, Berlin, Germany.
  • Bhatia S; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, CB3 0AS, UK.
  • Cheng C; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustr. 3, 14195, Berlin, Germany.
  • Stadtmüller M; College of Polymer Science and Engineering, Sichuan University, No.24 South Section 1, Yihuan Road, 610065, Chengdu, China.
  • Oehrl A; Unit 17, Robert Koch Institut, Seestr. 10, 13353, Berlin, Germany.
  • Kerkhoff Y; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustr. 3, 14195, Berlin, Germany.
  • Wolff T; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustr. 3, 14195, Berlin, Germany.
  • Haag R; Unit 17, Robert Koch Institut, Seestr. 10, 13353, Berlin, Germany.
Angew Chem Int Ed Engl ; 59(36): 15532-15536, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32421225
ABSTRACT
In this study, we demonstrate the concept of "topology-matching design" for virus inhibitors. With the current knowledge of influenza A virus (IAV), we designed a nanoparticle-based inhibitor (nano-inhibitor) that has a matched nanotopology to IAV virions and shows heteromultivalent inhibitory effects on hemagglutinin and neuraminidase. The synthesized nano-inhibitor can neutralize the viral particle extracellularly and block its attachment and entry to the host cells. The virus replication was significantly reduced by 6 orders of magnitude in the presence of the reverse designed nano-inhibitors. Even when used 24 hours after the infection, more than 99.999 % inhibition is still achieved, which indicates such a nano-inhibitor might be a potent antiviral for the treatment of influenza infection.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Vírus da Influenza A / Desenho de Fármacos / Influenza Humana / Zanamivir / Nanopartículas Limite: Animals / Humans Idioma: En Revista: Angew Chem Int Ed Engl Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Vírus da Influenza A / Desenho de Fármacos / Influenza Humana / Zanamivir / Nanopartículas Limite: Animals / Humans Idioma: En Revista: Angew Chem Int Ed Engl Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha